Industry News
Biotechnology Industry News

Attacking Alzheimer’s by protecting synapses from amyloid beta
Attacking Alzheimer's by protecting synapses from amyloid beta klahucik Tue, 08/17/2021 - 15:59
Lilly, with Alzheimer’s in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec
Lilly, with Alzheimer's in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec ntaylor Tue, 08/17/2021 - 07:48
Going big: Bain reels in $1.9B for more mammoth biotech bets
Going big: Bain reels in $1.9B for more mammoth biotech bets ntaylor Tue, 08/17/2021 - 06:02
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech badams Mon, 08/16/2021 - 10:49
Novartis-backed Penn study proposes boosting CAR-T responses in CLL by waking up ‘war weary’ T cells
Novartis-backed Penn study proposes boosting CAR-T responses in CLL by waking up 'war weary' T cells arlene.weintraub Mon, 08/16/2021 - 09:53
FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing
FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing ntaylor Mon, 08/16/2021 - 08:04
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on ntaylor Mon, 08/16/2021 - 06:12
Zombie biotech Sesen Bio’s resurrection plans limping again as FDA rejects bladder cancer drug
Zombie biotech Sesen Bio's resurrection plans limping again as FDA rejects bladder cancer drug badams Mon, 08/16/2021 - 04:41
PureTech Health, having built out internal pipeline, raids Freeline for CMO to oversee clinical trials
PureTech Health, having built out internal pipeline, raids Freeline for CMO to oversee clinical trials ntaylor Fri, 08/13/2021 - 08:07
Ipsen pulls FDA rare disease filing, dealing yet another blow to $1B bet on rare disease drug
Ipsen pulls FDA rare disease filing, dealing yet another blow to $1B bet on rare disease drug ntaylor Fri, 08/13/2021 - 06:00
Insights into the origin of esophageal cancer could boost early detection efforts
Insights into the origin of esophageal cancer could boost early detection efforts arlene.weintraub Thu, 08/12/2021 - 12:22
Merck NK cell ally Artiva splashes out on new digs in San Diego
Merck NK cell ally Artiva splashes out on new digs in San Diego ntaylor Thu, 08/12/2021 - 08:59
Leading longevity researcher accused of sexual harassment
Leading longevity researcher accused of sexual harassment ntaylor Thu, 08/12/2021 - 08:54
Aprea gets 2nd clinical hold in a week, this time for lymphoid malignancy study
Aprea gets 2nd clinical hold in a week, this time for lymphoid malignancy study badams Thu, 08/12/2021 - 08:38
Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility
Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility klahucik Wed, 08/11/2021 - 12:48
Overcoming resistance to cancer immunotherapy by targeting garbage-cleaning cells in tumors
Overcoming resistance to cancer immunotherapy by targeting garbage-cleaning cells in tumors aliu Wed, 08/11/2021 - 12:05
Purdue subsidiary buys non-opioid pain prospect from PureHealth
Purdue subsidiary buys non-opioid pain prospect from PureHealth ntaylor Wed, 08/11/2021 - 08:10
Purdue subsidiary buys non-opioid pain prospect from PureTech Health
Purdue subsidiary buys non-opioid pain prospect from PureTech Health ntaylor Wed, 08/11/2021 - 08:10
BioCryst scraps $200M offering after seeing share price slide
BioCryst scraps $200M offering after seeing share price slide ntaylor Wed, 08/11/2021 - 06:59
Eli Lilly takes its trial work on the road, literally, as it loads up RVs to broaden its study reach
Eli Lilly takes its trial work on the road, literally, as it loads up RVs to broaden its study reach badams Wed, 08/11/2021 - 04:26

